Skin Test Antigen [EPC]

Skin Test Antigen [EPC] was reported 1886 times

Drugs of the Skin Test Antigen [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 ELECTROMYOGRAM NORMAL 1 0.5000
1 TUBERCULIN TEST NEGATIVE 3 0.3333
2 VACCINATION SITE NECROSIS 1 0.3333
3 VACCINATION SITE IRRITATION 1 0.2000
4 VACCINATION SITE INDURATION 6 0.1765
5 VACCINATION SITE PRURITUS 8 0.1569
6 VACCINATION SITE RASH 6 0.1429
7 VACCINATION SITE INFLAMMATION 8 0.1404
8 VACCINATION SITE VESICLES 3 0.1364
9 EXTENSIVE SWELLING OF VACCINATED LIMB 3 0.1364
10 GASTROENTERITIS NORWALK VIRUS 2 0.1053
11 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST NEGATIVE 1 0.1000
12 VACCINATION SITE LYMPHADENOPATHY 1 0.1000
13 BLOOD CADMIUM INCREASED 1 0.0909
14 COW POX 1 0.0909
15 VACCINATION SITE CELLULITIS 2 0.0769
16 VACCINATION SITE ERYTHEMA 14 0.0648
17 VACCINATION SITE INFECTION 1 0.0625
18 TUBERCULIN TEST FALSE POSITIVE 7 0.0526
19 TUBERCULOSIS SKIN TEST POSITIVE 4 0.0494
20 MANUFACTURING PRODUCT STORAGE ISSUE 4 0.0476
21 BLADDER NECK OPERATION 1 0.0455
22 OVARIAN INFECTION 1 0.0435
23 VACCINATION SITE BRUISING 1 0.0417
24 POOR QUALITY PRODUCT ADMINISTERED 432 0.0409
25 VACCINATION SITE WARMTH 2 0.0339
26 VACCINATION SITE REACTION 4 0.0310
27 VACCINATION SITE OEDEMA 1 0.0303
28 POLYMORPHIC ERUPTION OF PREGNANCY 1 0.0286
29 OILY SKIN 1 0.0256
30 FALSE POSITIVE TUBERCULOSIS TEST 7 0.0222
31 URTICARIA LOCALISED 1 0.0213
32 INTRANASAL PARAESTHESIA 1 0.0200
33 FACTOR VII DEFICIENCY 1 0.0149
34 WRONG PRODUCT ADMINISTERED 98 0.0145
35 HISTAMINE ABNORMAL 1 0.0143
36 EXPOSURE VIA EYE CONTACT 6 0.0143
37 ERYTHEMA INDURATUM 2 0.0141
38 RENAL SCAN ABNORMAL 1 0.0141
39 VACCINATION SITE PAIN 7 0.0122
40 VACCINATION SITE SWELLING 2 0.0116
41 LYMPHOCYTE COUNT 1 0.0114
42 PARAESTHESIA MUCOSAL 1 0.0108
43 DIALYSIS HYPOTENSION 1 0.0101
44 ALLERGY TO VACCINE 3 0.0097
45 SYNCOPE VASOVAGAL 8 0.0097
46 RASH SCALY 1 0.0094
47 UNRESPONSIVE TO VERBAL STIMULI 2 0.0093
48 TRACHEAL INFLAMMATION 1 0.0092
49 TUBERCULIN TEST POSITIVE 20 0.0079
50 ARTERIOVENOUS FISTULA SITE INFECTION 1 0.0074
51 INCISION SITE OEDEMA 1 0.0072
52 INJECTED LIMB MOBILITY DECREASED 1 0.0070
53 BASAL GANGLIA STROKE 1 0.0069
54 INJECTION SITE DERMATITIS 1 0.0069
55 LOCAL REACTION 5 0.0067
56 OSTEOPOROSIS POSTMENOPAUSAL 1 0.0067
57 BRACHIAL PLEXUS INJURY 1 0.0062
58 INDURATION 11 0.0062
59 ACUTE CARDIAC EVENT 1 0.0058
60 ARTERIOVENOUS FISTULA OCCLUSION 1 0.0057
61 EYE ROLLING 4 0.0056
62 APPLICATION SITE HAEMATOMA 1 0.0055
63 SKIN INFLAMMATION 1 0.0051
64 SHOULDER DEFORMITY 1 0.0051
65 HEPATITIS A ANTIBODY POSITIVE 1 0.0051
66 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 86 0.0050
67 URTICARIA GENERALISED 3 0.0046
68 TESTICULAR MASS 1 0.0046
69 BRACHIAL PLEXOPATHY 1 0.0045
70 INJECTION SITE VESICLES 26 0.0043
71 VOCAL CORD PARESIS 1 0.0043
72 INJECTION SITE NERVE DAMAGE 1 0.0042
73 EXPIRED PRODUCT ADMINISTERED 139 0.0042
74 INJECTION SITE OEDEMA 7 0.0041
75 LATEX ALLERGY 1 0.0041
76 INJECTION SITE STREAKING 1 0.0040
77 ERYTHEMA INFECTIOSUM 1 0.0039
78 CORNEAL THINNING 1 0.0039
79 PRODUCT STORAGE ERROR 322 0.0037
80 AGONAL RESPIRATION 1 0.0035
81 SUBCUTANEOUS NODULE 1 0.0035
82 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED DRUG 1 0.0034
83 INJECTION SITE INFLAMMATION 17 0.0034
84 BLOOD CREATINE DECREASED 1 0.0033
85 WRONG DRUG ADMINISTERED 29 0.0033
86 INJECTION SITE INDURATION 42 0.0032
87 CORNEAL INFILTRATES 1 0.0032
88 LACUNAR STROKE 1 0.0031
89 LOSS OF PROPRIOCEPTION 1 0.0031
90 PARAKERATOSIS 1 0.0031
91 TONIC CLONIC MOVEMENTS 4 0.0031
92 ACANTHOSIS 1 0.0030
93 GAIT SPASTIC 1 0.0029
94 BASAL GANGLIA INFARCTION 1 0.0029
95 ANION GAP DECREASED 1 0.0029
96 BURNING SENSATION MUCOSAL 1 0.0028
97 LYMPHOID TISSUE HYPERPLASIA 1 0.0028
98 BRAIN CONTUSION 2 0.0027
99 SUSPECTED PRODUCT QUALITY ISSUE 5 0.0027
100 POOR QUALITY DRUG ADMINISTERED 17 0.0026
101 BOVINE TUBERCULOSIS 1 0.0026
102 INJECTION SITE BURNING 2 0.0026
103 CAT SCRATCH DISEASE 1 0.0025
104 LYMPHOCYTE PERCENTAGE INCREASED 1 0.0025
105 LACK OF SPONTANEOUS SPEECH 1 0.0023
106 PRODUCT WITH QUALITY ISSUE ADMINISTERED 1 0.0022
107 ENLARGED UVULA 1 0.0022
108 DRUG DETOXIFICATION 2 0.0022
109 ARTERIOVENOUS MALFORMATION 2 0.0022
110 SEXUALLY INAPPROPRIATE BEHAVIOUR 1 0.0021
111 SKIN TEST POSITIVE 2 0.0021
112 PRODUCT TEMPERATURE EXCURSION ISSUE 11 0.0021
113 STATUS ASTHMATICUS 1 0.0021
114 TONIC CONVULSION 3 0.0021
115 WOUND NECROSIS 1 0.0021
116 AXILLARY PAIN 3 0.0020
117 PULSE PRESSURE DECREASED 1 0.0020
118 KELOID SCAR 1 0.0019
119 POSTURING 1 0.0019
120 TRACHEAL DISORDER 1 0.0019
121 NO REACTION ON PREVIOUS EXPOSURE TO DRUG 1 0.0019
122 SKIN WARM 11 0.0019
123 ASPARTATE AMINOTRANSFERASE DECREASED 1 0.0019
124 NEUTROPHIL PERCENTAGE DECREASED 1 0.0019
125 TYPE III IMMUNE COMPLEX MEDIATED REACTION 1 0.0018
126 ORAL PRURITUS 4 0.0017
127 CORNEAL EPITHELIUM DEFECT 1 0.0017
128 TRANSAMINASES ABNORMAL 1 0.0017
129 OCCUPATIONAL EXPOSURE TO PRODUCT 11 0.0017
130 ARTERIOVENOUS FISTULA SITE COMPLICATION 1 0.0017
131 UNINTENTIONAL USE FOR UNAPPROVED INDICATION 1 0.0017
132 LYMPHADENITIS 4 0.0017
133 TOOTH EROSION 2 0.0016
134 CERVICOBRACHIAL SYNDROME 1 0.0016
135 CHEST X-RAY ABNORMAL 5 0.0016
136 INJECTION SITE CELLULITIS 3 0.0016
137 LYMPH NODE PAIN 3 0.0016
138 PERNICIOUS ANAEMIA 1 0.0016
139 SENSATION OF HEAVINESS 6 0.0015
140 BODY MASS INDEX INCREASED 2 0.0015
141 HEAD AND NECK CANCER 1 0.0015
142 INJECTION SITE NECROSIS 3 0.0015
143 SOFT TISSUE NECROSIS 1 0.0015
144 TONGUE PARALYSIS 1 0.0014
145 ANTERIOR CHAMBER CELL 1 0.0014
146 PROTEUS INFECTION 1 0.0014
147 ESCHAR 1 0.0014
148 LYMPH NODE TUBERCULOSIS 1 0.0013
149 HYPOAESTHESIA FACIAL 2 0.0013
150 INJECTION SITE PARAESTHESIA 2 0.0013
151 INJECTION SITE WARMTH 26 0.0013
152 THROAT TIGHTNESS 34 0.0013
153 SKIN BACTERIAL INFECTION 1 0.0012
154 EXCESSIVE GRANULATION TISSUE 1 0.0012
155 GUILLAIN-BARRE SYNDROME 6 0.0012
156 REACTION TO PRESERVATIVES 1 0.0012
157 ANAPHYLACTOID REACTION 5 0.0012
158 CULTURE POSITIVE 1 0.0012
159 LIP PRURITUS 1 0.0012
160 TONGUE PRURITUS 1 0.0012
161 INJECTION SITE DISCOLOURATION 14 0.0011
162 COLOUR BLINDNESS 1 0.0011
163 LOCALISED OEDEMA 5 0.0011
164 MENINGIOMA BENIGN 1 0.0011
165 PNEUMONIA CRYPTOCOCCAL 1 0.0011
166 BLOOD ALKALINE PHOSPHATASE DECREASED 1 0.0011
167 PHARYNGEAL OEDEMA 16 0.0010
168 PARAESTHESIA ORAL 15 0.0010
169 INJECTION SITE SCAB 1 0.0010
170 SHOULDER PAIN 1 0.0010
171 SKIN OEDEMA 1 0.0010
172 LYMPHOCYTIC INFILTRATION 1 0.0010
173 FALSE POSITIVE INVESTIGATION RESULT 1 0.0010
174 THROMBOPHLEBITIS SUPERFICIAL 3 0.0010
175 EAR HAEMORRHAGE 2 0.0010
176 SUSPECTED PRODUCT CONTAMINATION 1 0.0010
177 ALVEOLITIS ALLERGIC 1 0.0010
178 PERTUSSIS 1 0.0010
179 LIVEDO RETICULARIS 2 0.0010
180 CARPAL TUNNEL DECOMPRESSION 1 0.0009
181 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 1 0.0009
182 NEUROMYOPATHY 1 0.0009
183 INTRACRANIAL VENOUS SINUS THROMBOSIS 1 0.0009
184 IMMEDIATE POST-INJECTION REACTION 1 0.0009
185 NAIL GROWTH ABNORMAL 1 0.0009
186 OPEN WOUND 1 0.0009
187 PALLOR 24 0.0009
188 ADMINISTRATION SITE PAIN 1 0.0009
189 INJECTION SITE IRRITATION 11 0.0009
190 NEPHROGENIC ANAEMIA 4 0.0009
191 ALLODYNIA 1 0.0009
192 MULTIMORBIDITY 1 0.0008
193 CHRONIC RESPIRATORY FAILURE 1 0.0008
194 STARING 2 0.0008
195 PHARYNGEAL INFLAMMATION 1 0.0008
196 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 5 0.0008
197 BLOOD UREA DECREASED 1 0.0008
198 INJECTION SITE ABSCESS 2 0.0008
199 HYPERPARATHYROIDISM SECONDARY 2 0.0008
200 INJECTION SITE PRURITUS 53 0.0008
201 PRESYNCOPE 19 0.0008
202 ANGIONEUROTIC OEDEMA 2 0.0007
203 AREFLEXIA 2 0.0007
204 LARYNGOSPASM 2 0.0007
205 PRURITUS GENERALISED 16 0.0007
206 CARBON DIOXIDE INCREASED 1 0.0007
207 INJECTION SITE ERYTHEMA 91 0.0007
208 ACCIDENTAL EXPOSURE 3 0.0007
209 INCISIONAL HERNIA 1 0.0007
210 SERUM SICKNESS 2 0.0007
211 INJECTION SITE RASH 21 0.0007
212 INJECTION SITE REACTION 47 0.0007
213 STRIDOR 2 0.0007
214 COMPLEX REGIONAL PAIN SYNDROME 1 0.0007
215 INTERCEPTED DRUG DISPENSING ERROR 1 0.0007
216 INCORRECT ROUTE OF DRUG ADMINISTRATION 24 0.0007
217 INJECTION SITE PAPULE 3 0.0007
218 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 12 0.0007
219 PULMONARY FUNCTION TEST ABNORMAL 1 0.0006
220 INTERMITTENT CLAUDICATION 1 0.0006
221 SKULL FRACTURE 1 0.0006
222 SWOLLEN TONGUE 19 0.0006
223 PAPILLOMA VIRAL INFECTION 1 0.0006
224 VENA CAVA THROMBOSIS 1 0.0006
225 VACCINATION FAILURE 1 0.0006
226 SPINAL DEFORMITY 1 0.0006
227 SEIZURE LIKE PHENOMENA 1 0.0006
228 PHLEBITIS 3 0.0006
229 MYCOBACTERIAL INFECTION 1 0.0006
230 CHOREA 1 0.0006
231 ACUTE SINUSITIS 1 0.0006
232 RASH GENERALISED 15 0.0006
233 HYPOPNOEA 2 0.0006
234 TENDERNESS 6 0.0006
235 MENINGITIS CRYPTOCOCCAL 1 0.0006
236 EAR PRURITUS 2 0.0006
237 FOOD INTERACTION 1 0.0006
238 PHARYNGOLARYNGEAL PAIN 3 0.0006
239 MUSCLE CRAMP 1 0.0006
240 VOCAL CORD PARALYSIS 1 0.0006
241 ESSENTIAL HYPERTENSION 1 0.0005
242 OESOPHAGEAL SPASM 1 0.0005
243 GRAND MAL CONVULSION 5 0.0005
244 DYSENTERY 1 0.0005
245 AURA 1 0.0005
246 LIVING IN RESIDENTIAL INSTITUTION 1 0.0005
247 WHITE BLOOD CELLS URINE POSITIVE 1 0.0005
248 SACROILIITIS 1 0.0005
249 INJECTION SITE URTICARIA 13 0.0005
250 ANAPHYLACTIC REACTION 29 0.0005
251 CONVERSION DISORDER 1 0.0005
252 PURULENCE 1 0.0005
253 NASAL SEPTUM DEVIATION 1 0.0005
254 DERMATITIS PSORIASIFORM 1 0.0005
255 SELF-MEDICATION 2 0.0005
256 POLYCYTHAEMIA 1 0.0005
257 ATRIAL THROMBOSIS 1 0.0005
258 ERYTHEMA 99 0.0005
259 MICROCYTIC ANAEMIA 1 0.0005
260 LATENT TUBERCULOSIS 1 0.0005
261 DILATATION VENTRICULAR 1 0.0005
262 NEUROGENIC BLADDER 1 0.0005
263 PHARYNGEAL ERYTHEMA 1 0.0005
264 FACIAL PALSY 1 0.0005
265 MONOPLEGIA 2 0.0005
266 REACTION TO DRUG EXCIPIENTS 1 0.0005
267 CORNEAL DISORDER 1 0.0005
268 PURPURA 4 0.0005
269 RASH PAPULAR 10 0.0004
270 INFECTIOUS MONONUCLEOSIS 1 0.0004
271 APPLICATION SITE URTICARIA 1 0.0004
272 PERIARTHRITIS 1 0.0004
273 WHEEZING 26 0.0004
274 RESPIRATION ABNORMAL 3 0.0004
275 DROOLING 3 0.0004
276 EYELID DISORDER 1 0.0004
277 FLAT AFFECT 1 0.0004
278 ESCHERICHIA BACTERAEMIA 1 0.0004
279 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 1 0.0004
280 PRE-ECLAMPSIA 2 0.0004
281 EOSINOPHIL COUNT DECREASED 1 0.0004
282 VARICELLA 1 0.0004
283 PULSE ABNORMAL 1 0.0004
284 RASH VESICULAR 2 0.0004
285 PRODUCT PACKAGING CONFUSION 1 0.0004
286 URTICARIA 69 0.0004
287 HYPERNATRAEMIA 2 0.0004
288 RASH ERYTHEMATOUS 19 0.0004
289 VASODILATATION 1 0.0004
290 EXCORIATION 1 0.0004
291 PRODUCT CONTAMINATION PHYSICAL 1 0.0004
292 UNRESPONSIVE TO STIMULI 10 0.0004
293 CYANOSIS 6 0.0004
294 THROAT IRRITATION 17 0.0004
295 NYSTAGMUS 2 0.0004
296 SKIN DISCOMFORT 1 0.0004
297 SYNCOPE 37 0.0004
298 RASH PRURITIC 20 0.0004
299 HYPERAESTHESIA 3 0.0004
300 NONSPECIFIC REACTION 2 0.0004
301 DEAFNESS UNILATERAL 2 0.0004
302 TENOSYNOVITIS 1 0.0004
303 PROCTITIS 1 0.0004
304 SENSATION OF FOREIGN BODY 3 0.0004
305 PREMATURE LABOUR 2 0.0004
306 NECK MASS 1 0.0004
307 INJECTION SITE SWELLING 27 0.0004
308 JOINT LOCK 1 0.0004
309 GENERALISED ERYTHEMA 2 0.0004
310 DYSPNOEA AT REST 1 0.0003
311 ESCHERICHIA SEPSIS 1 0.0003
312 RASH MACULAR 12 0.0003
313 FEELING HOT 21 0.0003
314 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
315 WRONG PATIENT RECEIVED PRODUCT 1 0.0003
316 NECK INJURY 1 0.0003
317 CREPITATIONS 1 0.0003
318 HYPOAESTHESIA ORAL 5 0.0003
319 LOSS OF EMPLOYMENT 1 0.0003
320 LIP SWELLING 11 0.0003
321 EMERGENCY CARE 1 0.0003
322 EMBOLISM VENOUS 1 0.0003
323 DYSAESTHESIA 1 0.0003
324 DIASTOLIC DYSFUNCTION 1 0.0003
325 CHEST DISCOMFORT 33 0.0003
326 ERYTHEMA MULTIFORME 3 0.0003
327 BLOOD BLISTER 1 0.0003
328 INJECTION SITE HYPERSENSITIVITY 1 0.0003
329 BLADDER PAIN 1 0.0003
330 HYPERSENSITIVITY 58 0.0003
331 VENTRICULAR HYPOKINESIA 1 0.0003
332 LYMPHADENOPATHY 11 0.0003
333 ATELECTASIS 3 0.0003
334 LOOSE TOOTH 1 0.0003
335 POSTURE ABNORMAL 1 0.0003
336 PHARYNGEAL SWELLING 3 0.0003
337 OEDEMA MOUTH 1 0.0003
338 THROMBOSIS IN DEVICE 1 0.0003
339 INJECTION SITE INFECTION 1 0.0003
340 NEAR DEATH EXPERIENCE 1 0.0003
341 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1 0.0003
342 CYTOLYTIC HEPATITIS 1 0.0003
343 LYME DISEASE 1 0.0003
344 CELLULITIS 15 0.0003
345 EYE MOVEMENT DISORDER 2 0.0003
346 SWELLING FACE 19 0.0003
347 ECCHYMOSIS 2 0.0003
348 PUSTULAR PSORIASIS 1 0.0003
349 INFLAMMATION 15 0.0003
350 VIITH NERVE PARALYSIS 1 0.0003
351 ENCEPHALITIS 2 0.0003
352 GRANULOMA 1 0.0003
353 PETECHIAE 3 0.0003
354 FEELING COLD 8 0.0003
355 LOCAL SWELLING 5 0.0003
356 MASS 4 0.0003
357 MUSCLE CONTRACTIONS INVOLUNTARY 1 0.0003
358 HANGOVER 1 0.0003
359 TYPE I HYPERSENSITIVITY 1 0.0003
360 COLD SWEAT 5 0.0003
361 FACIAL PARESIS 1 0.0003
362 HAEMORRHAGE SUBCUTANEOUS 1 0.0003
363 BREAST PAIN 3 0.0003
364 INTERCEPTED PRODUCT STORAGE ERROR 1 0.0003
365 LETHARGY 16 0.0003
366 LIVER TRANSPLANT 1 0.0003
367 CUTANEOUS VASCULITIS 1 0.0003
368 THROMBOCYTOSIS 1 0.0003
369 EXTRA DOSE ADMINISTERED 11 0.0003
370 MEDICATION ERROR 15 0.0003
371 PHARMACEUTICAL PRODUCT COMPLAINT 7 0.0003
372 HYPERACUSIS 1 0.0003
373 PRURITUS 103 0.0003
374 CHRONIC SINUSITIS 1 0.0003
375 PROTEIN TOTAL DECREASED 1 0.0003
376 PAROSMIA 2 0.0003
377 PARANASAL SINUS DISCOMFORT 1 0.0003
378 CONVULSION 15 0.0003
379 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
380 THYROID MASS 1 0.0003
381 WOUND SECRETION 1 0.0003
382 RESPIRATORY ACIDOSIS 1 0.0003
383 BLOOD ALBUMIN DECREASED 2 0.0003
384 MYOCLONUS 3 0.0003
385 MUSCLE RIGIDITY 3 0.0003
386 SENSORY DISTURBANCE 4 0.0002
387 MUSCLE HAEMORRHAGE 1 0.0002
388 TRIGEMINAL NEURALGIA 1 0.0002
389 SENSORY LOSS 2 0.0002
390 MATERNAL EXPOSURE DURING BREAST FEEDING 1 0.0002
391 ACCIDENTAL OVERDOSE 9 0.0002
392 APPLICATION SITE EXFOLIATION 1 0.0002
393 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
394 FACE OEDEMA 4 0.0002
395 SKIN PLAQUE 2 0.0002
396 LIP OEDEMA 1 0.0002
397 DRUG EXPOSURE DURING PREGNANCY 8 0.0002
398 PURULENT DISCHARGE 1 0.0002
399 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
400 TEARFULNESS 1 0.0002
401 BLISTER 13 0.0002
402 STAPHYLOCOCCAL BACTERAEMIA 1 0.0002
403 RESPIRATORY RATE INCREASED 2 0.0002
404 RASH MACULO-PAPULAR 5 0.0002
405 RHINITIS ALLERGIC 1 0.0002
406 SWELLING 21 0.0002
407 PARAESTHESIA 35 0.0002
408 OROPHARYNGEAL DISCOMFORT 2 0.0002
409 DYSPHAGIA 21 0.0002
410 TACHYPNOEA 3 0.0002
411 END STAGE RENAL DISEASE 4 0.0002
412 SKIN LESION 6 0.0002
413 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
414 FLUSHING 22 0.0002
415 BURNING SENSATION 15 0.0002
416 SKIN REACTION 3 0.0002
417 DIALYSIS 3 0.0002
418 BLOOD PRESSURE DECREASED 14 0.0002
419 SARCOIDOSIS 1 0.0002
420 VIRAL UPPER RESPIRATORY TRACT INFECTION 1 0.0002
421 GESTATIONAL DIABETES 1 0.0002
422 SUBCUTANEOUS ABSCESS 1 0.0002
423 HYPOAESTHESIA 31 0.0002
424 INCORRECT DOSAGE ADMINISTERED 1 0.0002
425 EXPIRED DRUG ADMINISTERED 1 0.0002
426 ABDOMINAL TENDERNESS 1 0.0002
427 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
428 BODY TEMPERATURE INCREASED 4 0.0002
429 PETIT MAL EPILEPSY 1 0.0002
430 EAR DISCOMFORT 2 0.0002
431 INCREASED UPPER AIRWAY SECRETION 1 0.0002
432 LIMB DISCOMFORT 6 0.0002
433 SKIN NECROSIS 1 0.0002
434 PERIORBITAL OEDEMA 1 0.0002
435 TONSILLITIS 1 0.0002
436 CATATONIA 1 0.0002
437 SCRATCH 2 0.0002
438 EYE SWELLING 7 0.0002
439 DYSPHONIA 11 0.0002
440 INJECTION SITE DISCHARGE 1 0.0002
441 HYPERKERATOSIS 1 0.0002
442 DENTAL CARIES 2 0.0002
443 OEDEMA PERIPHERAL 22 0.0002
444 HYPERTENSIVE CRISIS 2 0.0002
445 STREPTOCOCCAL INFECTION 1 0.0002
446 LOSS OF CONSCIOUSNESS 23 0.0002
447 MALNUTRITION 2 0.0002
448 ANGIOPATHY 1 0.0002
449 UPPER GASTROINTESTINAL HAEMORRHAGE 3 0.0002
450 SKIN INFECTION 2 0.0002
451 MULTIPLE USE OF SINGLE-USE PRODUCT 1 0.0002
452 BLOOD CALCIUM DECREASED 2 0.0002
453 HEMIPARESIS 3 0.0002
454 COLECTOMY 1 0.0002
455 PERONEAL NERVE PALSY 1 0.0002
456 DYSGEUSIA 13 0.0002
457 CARDIAC VALVE DISEASE 1 0.0002
458 EXERCISE TOLERANCE DECREASED 1 0.0002
459 HYPERVENTILATION 1 0.0002
460 DYSKINESIA 7 0.0002
461 EYELID OEDEMA 2 0.0002
462 OVERDOSE 37 0.0002
463 DYSPNOEA 97 0.0002
464 HEART RATE DECREASED 6 0.0002
465 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
466 CHILLS 20 0.0002
467 PROTHROMBIN TIME PROLONGED 1 0.0002
468 RESPIRATORY DISORDER 5 0.0002
469 LEUKOCYTOSIS 3 0.0002
470 MUSCLE SPASTICITY 2 0.0002
471 SCOLIOSIS 1 0.0002
472 MIDDLE INSOMNIA 3 0.0002
473 INJECTION SITE PAIN 49 0.0002
474 DERMATITIS ALLERGIC 2 0.0002
475 PHOTOPSIA 1 0.0002
476 HYPERHIDROSIS 20 0.0002
477 HEPATITIS ACUTE 1 0.0002
478 PALPITATIONS 18 0.0002
479 NODULE 2 0.0002
480 SKIN IRRITATION 7 0.0002
481 PULMONARY CONGESTION 2 0.0002
482 APPETITE DISORDER 1 0.0002
483 BRADYCARDIA 8 0.0002
484 MENINGITIS 1 0.0001
485 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
486 JOINT RANGE OF MOTION DECREASED 2 0.0001
487 RASH 65 0.0001
488 PRODUCT LABEL ISSUE 1 0.0001
489 PERIPHERAL COLDNESS 2 0.0001
490 RESPIRATORY DISTRESS 4 0.0001
491 LYMPHOEDEMA 1 0.0001
492 INCORRECT DOSE ADMINISTERED 33 0.0001
493 FORMICATION 1 0.0001
494 APHONIA 2 0.0001
495 DUODENAL ULCER 1 0.0001
496 HEART RATE INCREASED 14 0.0001
497 THERMAL BURN 1 0.0001
498 FEAR OF INJECTION 1 0.0001
499 BRONCHOSPASM 2 0.0001
500 TONGUE DISORDER 1 0.0001
501 INJECTION SITE HAEMATOMA 2 0.0001
502 FLUID OVERLOAD 2 0.0001
503 ORAL DISORDER 1 0.0001
504 MELAENA 3 0.0001
505 ANGIOEDEMA 6 0.0001
506 BLINDNESS TRANSIENT 1 0.0001
507 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
508 HYDRONEPHROSIS 1 0.0001
509 PYREXIA 46 0.0001
510 AORTIC ANEURYSM 1 0.0001
511 ACIDOSIS 1 0.0001
512 DIZZINESS 65 0.0001
513 MUSCLE TWITCHING 3 0.0001
514 DEVICE RELATED INFECTION 2 0.0001
515 FOOD ALLERGY 1 0.0001
516 ATRIOVENTRICULAR BLOCK 1 0.0001
517 PULMONARY HAEMORRHAGE 1 0.0001
518 HEAD INJURY 4 0.0001
519 RENAL CYST 1 0.0001
520 RESPIRATORY TRACT CONGESTION 2 0.0001
521 ULCER 2 0.0001
522 ATRIAL FLUTTER 1 0.0001
523 BLOOD PRESSURE FLUCTUATION 3 0.0001
524 ABORTION SPONTANEOUS 5 0.0001
525 MUSCLE TIGHTNESS 2 0.0001
526 BLOOD POTASSIUM INCREASED 2 0.0001
527 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 1 0.0001
528 ATRIAL SEPTAL DEFECT 1 0.0001
529 NASAL CONGESTION 7 0.0001
530 PAIN IN EXTREMITY 35 0.0001
531 CANDIDA INFECTION 2 0.0001
532 FACIAL PARALYSIS 1 0.0001
533 SCAR 2 0.0001
534 ANAPHYLACTIC SHOCK 3 0.0001
535 BLOOD MAGNESIUM DECREASED 1 0.0001
536 EXPOSURE VIA SKIN CONTACT 3 0.0001
537 SKIN SWELLING 1 0.0001
538 TREMOR 19 0.0001
539 MUSCULAR WEAKNESS 13 0.0001
540 SPINAL OSTEOARTHRITIS 1 0.0001
541 TUMOUR LYSIS SYNDROME 1 0.0001
542 GRIP STRENGTH DECREASED 1 0.0001
543 LUNG INFILTRATION 1 0.0001
544 LYMPHOCYTE COUNT DECREASED 2 0.0001
545 GASTROINTESTINAL INFECTION 1 0.0001
546 MYOSITIS 1 0.0001
547 ANAL INCONTINENCE 1 0.0001
548 PNEUMONIA BACTERIAL 1 0.0001
549 BRAIN NEOPLASM 1 0.0001
550 SKIN DISCOLOURATION 5 0.0001
551 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
552 CHEST PAIN 20 0.0001
553 CONJUNCTIVITIS 2 0.0001
554 NEPHROPATHY 1 0.0001
555 PHOTOPHOBIA 2 0.0001
556 LACERATION 1 0.0001
557 OCULAR HYPERAEMIA 5 0.0001
558 POST PROCEDURAL COMPLICATION 2 0.0001
559 DIZZINESS POSTURAL 1 0.0001
560 VITAMIN D DEFICIENCY 1 0.0001
561 RENAL TUBULAR NECROSIS 1 0.0001
562 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
563 HEPATOMEGALY 1 0.0001
564 BODY TEMPERATURE DECREASED 1 0.0001
565 URINARY INCONTINENCE 3 0.0001
566 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
567 HAEMATOCRIT DECREASED 2 0.0001
568 HYPOTONIA 1 0.0001
569 PRODUCT ADMINISTRATION ERROR 2 0.0001
570 SUBARACHNOID HAEMORRHAGE 1 0.0001
571 NEUTROPHIL COUNT DECREASED 4 0.0001
572 NEUTROPHIL COUNT INCREASED 1 0.0001
573 OROPHARYNGEAL PAIN 9 0.0001
574 TEMPERATURE INTOLERANCE 1 0.0001
575 HYPERBILIRUBINAEMIA 1 0.0001
576 ASTHENIA 36 0.0001
577 GASTROINTESTINAL HAEMORRHAGE 8 0.0001
578 WEIGHT FLUCTUATION 1 0.0001
579 SPEECH DISORDER 5 0.0001
580 INJECTION SITE DISCOMFORT 1 0.0001
581 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
582 INCONTINENCE 1 0.0001
583 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
584 COUGH 26 0.0001
585 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
586 BIPOLAR DISORDER 1 0.0001
587 BACK INJURY 1 0.0001
588 BLOOD PRESSURE INCREASED 14 0.0001
589 ASPIRATION 1 0.0001
590 STAPHYLOCOCCAL INFECTION 3 0.0001
591 INJECTION SITE NODULE 1 0.0001
592 STEVENS-JOHNSON SYNDROME 2 0.0001
593 NERVE INJURY 1 0.0001
594 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
595 NAUSEA 71 0.0001
596 EYE PRURITUS 3 0.0001
597 SNEEZING 2 0.0001
598 STATUS EPILEPTICUS 1 0.0001
599 IMPAIRED DRIVING ABILITY 1 0.0001
600 SCAB 1 0.0001
601 INJECTION SITE HAEMORRHAGE 7 0.0001
602 UNINTENTIONAL MEDICAL DEVICE REMOVAL 1 0.0001
603 HYPOTENSION 17 0.0001
604 HEPATITIS C 1 0.0001
605 SCHIZOPHRENIA 1 0.0001
606 NEURALGIA 2 0.0001
607 RESPIRATORY DEPRESSION 1 0.0001
608 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
609 SPINAL OPERATION 1 0.0001
610 ABASIA 2 0.0001
611 GENERALISED OEDEMA 1 0.0001
612 ILEUS 1 0.0001
613 EXPOSURE DURING PREGNANCY 5 0.0001
614 HAIR COLOUR CHANGES 1 0.0001
615 SECRETION DISCHARGE 1 0.0001
616 DYSARTHRIA 3 0.0001
617 HAEMATEMESIS 2 0.0001
618 HYPOPHAGIA 2 0.0001
619 NO ADVERSE EVENT 14 0.0001
620 AMNESIA 5 0.0001
621 PLATELET COUNT INCREASED 1 0.0001
622 INCORRECT PRODUCT STORAGE 1 0.0001
623 BEDRIDDEN 1 0.0001
624 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
625 INJECTION SITE BRUISING 6 0.0001
626 HEADACHE 47 0.0001
627 FEAR 2 0.0001
628 GINGIVAL BLEEDING 1 0.0001
629 HAEMATOCHEZIA 4 0.0001
630 MENTAL STATUS CHANGES 2 0.0001
631 ORAL DISCOMFORT 1 0.0001
632 COORDINATION ABNORMAL 1 0.0001
633 DEVICE OCCLUSION 1 0.0001
634 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
635 SEASONAL ALLERGY 1 0.0001
636 RED BLOOD CELL COUNT DECREASED 2 0.0001
637 BALANCE DISORDER 6 0.0001
638 SEIZURE 8 0.0001
639 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
640 HYPOKINESIA 1 0.0001
641 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
642 GASTROENTERITIS 1 0.0001
643 MUSCULOSKELETAL STIFFNESS 6 0.0001
644 PAIN 42 0.0001
645 TACHYCARDIA 6 0.0001
646 DEHYDRATION 9 0.0001
647 PULMONARY MASS 1 0.0001
648 PULMONARY OEDEMA 3 0.0001
649 HAEMORRHAGE INTRACRANIAL 1 0.0001
650 FEELING ABNORMAL 16 0.0001
651 LACRIMATION INCREASED 2 0.0001
652 OSTEOPENIA 1 0.0001
653 DISCOMFORT 4 0.0001
654 DRUG DISPENSING ERROR 1 0.0001
655 TINNITUS 3 0.0001
656 THYROID DISORDER 1 0.0001
657 MUSCULOSKELETAL CHEST PAIN 1 0.0001
658 TENDONITIS 1 0.0001
659 LUNG INFECTION 1 0.0001
660 VOMITING 30 0.0001
661 OBESITY 1 0.0001
662 ABSCESS 1 0.0001
663 CONTUSION 6 0.0001
664 MOVEMENT DISORDER 2 0.0001
665 ASTHMA 7 0.0001
666 RHINORRHOEA 4 0.0001
667 LUNG DISORDER 3 0.0001
668 CHOLELITHIASIS 2 0.0001
669 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
670 INFUSION RELATED REACTION 4 0.0001
671 VIRAL INFECTION 2 0.0001
672 SKIN DISORDER 2 0.0001
673 ANXIETY 17 0.0001
674 TYPE 2 DIABETES MELLITUS 2 0.0001
675 MALAISE 26 0.0001
676 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
677 PRODUCT QUALITY ISSUE 8 0.0001
678 ACCIDENTAL EXPOSURE TO PRODUCT 6 0.0001
679 MUSCULOSKELETAL DISCOMFORT 1 0.0001
680 GAIT DISTURBANCE 11 0.0001
681 ORTHOSTATIC HYPOTENSION 1 0.0001
682 ECZEMA 3 0.0001
683 MUSCULOSKELETAL PAIN 3 0.0001
684 AMENORRHOEA 1 0.0001
685 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
686 HEAD DISCOMFORT 1 0.0001
687 ISCHAEMIC STROKE 1 0.0001
688 CEREBRAL HAEMORRHAGE 2 0.0001
689 SYNOVITIS 1 0.0001
690 OSTEOMYELITIS 1 0.0001
691 CRYING 2 0.0001
692 RESTLESSNESS 2 0.0001
693 DYSURIA 2 0.0001
694 AGRANULOCYTOSIS 1 0.0001
695 NECK PAIN 3 0.0001
696 OXYGEN SATURATION DECREASED 3 0.0001
697 EYE PAIN 3 0.0001
698 RENAL FAILURE 7 0.0001
699 MUSCULOSKELETAL DISORDER 1 0.0001
700 SLEEP APNOEA SYNDROME 1 0.0001
701 EYE IRRITATION 3 0.0001
702 DRUG PRESCRIBING ERROR 1 0.0001
703 HERNIA 1 0.0001
704 ERUCTATION 1 0.0001
705 EAR PAIN 1 0.0001
706 VISION BLURRED 7 0.0001
707 SINUS DISORDER 1 0.0001
708 BLOOD PRESSURE ABNORMAL 1 0.0001
709 PREGNANCY 1 0.0000
710 SPINAL FRACTURE 1 0.0000
711 VERTIGO 3 0.0000
712 BLINDNESS 2 0.0000
713 HAEMOGLOBIN DECREASED 5 0.0000
714 INFLUENZA LIKE ILLNESS 4 0.0000
715 TOOTH LOSS 1 0.0000
716 ARTHRALGIA 20 0.0000
717 PULMONARY HYPERTENSION 1 0.0000
718 DERMATITIS 1 0.0000
719 BACK PAIN 11 0.0000
720 ANAEMIA 9 0.0000
721 OSTEOARTHRITIS 2 0.0000
722 MYALGIA 8 0.0000
723 EATING DISORDER 1 0.0000
724 IMPAIRED WORK ABILITY 1 0.0000
725 IRRITABLE BOWEL SYNDROME 1 0.0000
726 LIVER FUNCTION TEST INCREASED 1 0.0000
727 DEEP VEIN THROMBOSIS 3 0.0000
728 PERIPHERAL SWELLING 7 0.0000
729 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
730 SEPSIS 5 0.0000
731 GLOSSODYNIA 1 0.0000
732 THERAPY NON-RESPONDER 2 0.0000
733 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 9 0.0000
734 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 8 0.0000
735 MUSCLE SPASMS 8 0.0000
736 SHOCK 1 0.0000
737 HYPOKALAEMIA 2 0.0000
738 CONFUSIONAL STATE 7 0.0000
739 INJURY 3 0.0000
740 FATIGUE 33 0.0000
741 PRODUCT PRESCRIBING ERROR 1 0.0000
742 PRODUCTIVE COUGH 2 0.0000
743 MOBILITY DECREASED 3 0.0000
744 BLOOD GLUCOSE DECREASED 2 0.0000
745 INFECTION 6 0.0000
746 JOINT SWELLING 5 0.0000
747 HYPOGLYCAEMIA 2 0.0000
748 RESPIRATORY FAILURE 3 0.0000
749 FIBROMYALGIA 1 0.0000
750 UNDERDOSE 3 0.0000
751 AGITATION 3 0.0000
752 ENCEPHALOPATHY 1 0.0000
753 ACNE 3 0.0000
754 ABDOMINAL PAIN LOWER 1 0.0000
755 CHRONIC KIDNEY DISEASE 3 0.0000
756 FALL 13 0.0000
757 SINUSITIS 4 0.0000
758 DIPLOPIA 1 0.0000
759 RESPIRATORY TRACT INFECTION 1 0.0000
760 DEAFNESS 1 0.0000
761 JOINT STIFFNESS 1 0.0000
762 ANHEDONIA 1 0.0000
763 GASTRITIS 1 0.0000
764 CARDIAC FAILURE CONGESTIVE 3 0.0000
765 PAIN OF SKIN 1 0.0000
766 DISTURBANCE IN ATTENTION 2 0.0000
767 FREQUENT BOWEL MOVEMENTS 1 0.0000
768 BLOOD BILIRUBIN INCREASED 1 0.0000
769 OEDEMA 2 0.0000
770 LIMB INJURY 1 0.0000
771 TREATMENT NONCOMPLIANCE 2 0.0000
772 HAEMOPTYSIS 1 0.0000
773 DEMENTIA 1 0.0000
774 WOUND 1 0.0000
775 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
776 PAIN IN JAW 1 0.0000
777 ANGINA PECTORIS 1 0.0000
778 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
779 ABDOMINAL PAIN 8 0.0000
780 LIVER FUNCTION TEST ABNORMAL 1 0.0000
781 BONE PAIN 2 0.0000
782 ASCITES 1 0.0000
783 PSYCHOTIC DISORDER 1 0.0000
784 INSOMNIA 9 0.0000
785 RENAL INJURY 1 0.0000
786 BLOOD POTASSIUM DECREASED 1 0.0000
787 HEPATIC FAILURE 1 0.0000
788 APHASIA 1 0.0000
789 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
790 PLEURAL EFFUSION 2 0.0000
791 EPILEPSY 1 0.0000
792 DRUG ADMINISTRATION ERROR 1 0.0000
793 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
794 ADVERSE EVENT 3 0.0000
795 HOSPITALISATION 5 0.0000
796 NERVOUS SYSTEM DISORDER 1 0.0000
797 PRODUCT USE ISSUE 6 0.0000
798 CYSTITIS 1 0.0000
799 HIP FRACTURE 1 0.0000
800 PRODUCT DOSE OMISSION 2 0.0000
801 BLOOD CREATININE INCREASED 2 0.0000
802 IMPAIRED HEALING 1 0.0000
803 EYE DISORDER 1 0.0000
804 DECREASED APPETITE 7 0.0000
805 FUNGAL INFECTION 1 0.0000
806 URINARY RETENTION 1 0.0000
807 ABDOMINAL DISCOMFORT 5 0.0000
808 HAEMATURIA 1 0.0000
809 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
810 MEMORY IMPAIRMENT 4 0.0000
811 DELIRIUM 1 0.0000
812 HYPERKALAEMIA 1 0.0000
813 HYPOXIA 1 0.0000
814 SKIN BURNING SENSATION 2 0.0000
815 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
816 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
817 NASOPHARYNGITIS 5 0.0000
818 BRONCHITIS 2 0.0000
819 THROMBOCYTOPENIA 3 0.0000
820 HEPATIC FUNCTION ABNORMAL 1 0.0000
821 DYSPNOEA EXERTIONAL 1 0.0000
822 HALLUCINATION 2 0.0000
823 ABNORMAL BEHAVIOUR 1 0.0000
824 DISORIENTATION 1 0.0000
825 CARDIAC FAILURE 2 0.0000
826 ABDOMINAL PAIN UPPER 5 0.0000
827 ROAD TRAFFIC ACCIDENT 1 0.0000
828 RENAL FAILURE ACUTE 1 0.0000
829 URINARY TRACT INFECTION 4 0.0000
830 HYPOACUSIS 1 0.0000
831 SEPTIC SHOCK 1 0.0000
832 DRY SKIN 3 0.0000
833 GASTROINTESTINAL DISORDER 2 0.0000
834 DIARRHOEA 14 0.0000
835 PNEUMONIA 7 0.0000
836 BLOOD CHOLESTEROL INCREASED 1 0.0000
837 COGNITIVE DISORDER 1 0.0000
838 NEUROPATHY PERIPHERAL 2 0.0000
839 MIGRAINE 2 0.0000
840 ATRIAL FIBRILLATION 2 0.0000
841 DYSPEPSIA 2 0.0000
842 FLUID RETENTION 1 0.0000
843 ACUTE KIDNEY INJURY 3 0.0000
844 ILLNESS 2 0.0000
845 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
846 NERVOUSNESS 1 0.0000
847 PLATELET COUNT DECREASED 2 0.0000
848 DRUG EFFECT DECREASED 1 0.0000
849 ARTHROPATHY 1 0.0000
850 INFLUENZA 2 0.0000
851 PANCYTOPENIA 1 0.0000
852 HYPONATRAEMIA 1 0.0000
853 FLATULENCE 1 0.0000
854 RHEUMATOID ARTHRITIS 2 0.0000
855 HERPES ZOSTER 1 0.0000
856 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
857 IRRITABILITY 1 0.0000
858 EMOTIONAL DISTRESS 2 0.0000
859 SUICIDE ATTEMPT 1 0.0000
860 STOMATITIS 1 0.0000
861 BLOOD GLUCOSE INCREASED 3 0.0000
862 DEVICE EXPULSION 1 0.0000
863 PSORIASIS 2 0.0000
864 FEBRILE NEUTROPENIA 1 0.0000
865 HEPATIC ENZYME INCREASED 1 0.0000
866 WEIGHT DECREASED 4 0.0000
867 SLEEP DISORDER 1 0.0000
868 HYPERTENSION 3 0.0000
869 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
870 HOT FLUSH 1 0.0000
871 UNEVALUABLE EVENT 1 0.0000
872 DEPRESSION 3 0.0000
873 CONDITION AGGRAVATED 4 0.0000
874 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
875 DRY MOUTH 1 0.0000
876 CARDIAC ARREST 1 0.0000
877 DRUG ABUSE 1 0.0000
878 RENAL IMPAIRMENT 1 0.0000
879 SKIN EXFOLIATION 1 0.0000
880 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
881 DRUG WITHDRAWAL SYNDROME 1 0.0000
882 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
883 DEVICE ISSUE 1 0.0000
884 ADVERSE DRUG REACTION 1 0.0000
885 SUICIDAL IDEATION 1 0.0000
886 PULMONARY EMBOLISM 1 0.0000
887 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
888 DEATH 8 0.0000
889 DRUG INEFFECTIVE 11 0.0000
890 VISUAL IMPAIRMENT 1 0.0000
891 NEUTROPENIA 1 0.0000
892 DRUG DEPENDENCE 1 0.0000
893 TOXICITY TO VARIOUS AGENTS 1 0.0000
894 CEREBROVASCULAR ACCIDENT 1 0.0000
895 MYOCARDIAL INFARCTION 1 0.0000
896 ALOPECIA 1 0.0000
897 SOMNOLENCE 1 0.0000
898 CONSTIPATION 1 0.0000
899 OFF LABEL USE 4 0.0000